Skip to content
thispeptide

Peptivo

Peptivo presents online care across weight, recovery and healthy aging. Its public treatment terms name prescription products, but the homepage leaves the applicable clinical team and several preparation details unresolved.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

Confirm who will evaluate you, the actual formulation and the renewal terms before paying. The site describes provider review, but illustrative treatment formats and care scenarios do not establish the available prescription or a patient’s outcome.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Peptivo markets telehealth consultations for compounded semaglutide, tirzepatide, sermorelin and NAD+. Separate terms also describe branded Ozempic and Zepbound packages. The homepage organizes care by goals and shows injection, oral, nasal and topical concepts. It expressly calls those formats illustrative and says availability and formulation vary. That warning matters: a format pictured beside a treatment is not enough to confirm the preparation available to a particular patient.

What Peptivo prescribes, by goal

Weight

  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    • TirzepatideFDA-approved

      Listed by the seller; no price we hold.

      The terms name both compounded medicines and branded products. Confirm which is being prescribed rather than treating the active ingredient as proof of branded approval. Public format illustrations do not establish the route attached to each priced plan.

      Longevity

      • NAD+Compounding conditions apply

        Listed by the seller; no price we hold.

        Sermorelin and NAD+ are named in the service terms. The homepage’s broad recovery and aging themes do not establish a measured benefit from either preparation. The clinician should explain the intended use, limitations and monitoring.

        Recovery

        • SermorelinCompounding conditions apply

          Listed by the seller; no price we hold.

          Sleep

          • SermorelinCompounding conditions apply

            Listed by the seller; no price we hold.

            Who prescribes

            A licensed clinician

            A licensed provider reviews health history and decides whether treatment is appropriate. The homepage acknowledges that the applicable verified provider roster should be displayed, but does not supply that roster. The site does not name the assigned medical group or clinician, and a specific dispensing pharmacy is not identified. Ask for the practice name, clinician and pharmacy before agreeing to a prescription plan.

            The service begins with an online assessment about goals and history. A provider reviews that information before any treatment decision; prescription approval is not guaranteed. The site describes ongoing questions, care updates and messaging. Messaging can be sent anytime, while response times vary. That does not promise an immediate clinical reply or establish a regular visit schedule.

            Are labs required?

            Not established publicly

            A required baseline panel, laboratory charge and repeat-testing schedule were not established in the public program descriptions. Confirm these for the proposed treatment before paying.

            Ready to start with Peptivo?

            Prices and plans are set on the seller's own site.

            What it claims, and what it cites

            The homepage labels its portraits and stories as illustrative scenarios rather than actual patient reviews or treatment outcomes. They should not be read as evidence of clinical results. Its large patient-count claim is not a published controlled study. The site also acknowledges that compounded medications are not FDA-approved. Provider review is a care step, not proof that every proposed wellness use is established.

            How it bills

            The terms list semaglutide at $179 for initial and follow-up packages, and tirzepatide at $279. Sermorelin and NAD+ each show a $99 first month followed by $199. Consultation, medication, shipping and support are described as included. Product route and the complete dose scope still need confirmation. Refund eligibility is narrow: initial medical disqualification or a billing error, subject to stated conditions. Requests must be written within 28 days. The terms otherwise make prescription orders nonrefundable once intake is submitted. Cancellation after a processed subscription charge prevents future charges rather than refunding that charge. A routine cancellation method and notice cutoff were not established.

            For and against

            • For: Licensed review before treatment
            • For: Illustrative stories clearly labeled
            • For: Initial and follow-up figures distinguished
            • For: Refund limits available publicly
            • Against: Applicable clinical roster not shown
            • Against: Pharmacy identity remains unclear
            • Against: Treatment formats labeled illustrative
            • Against: Lab and routine cancellation details incomplete

            The evidence behind what it sells

            Right for

            Someone willing to obtain the exact clinical practice, product and written renewal terms before deciding whether the service fits.

            Look elsewhere if

            A patient who needs a named prescribing team, verified preparation and complete public monitoring plan before starting.

            Other sellers for weight

            Peptivo

            Frequently asked questions

            Are the homepage stories verified patient outcomes?
            No. The current page labels them illustrative scenarios and portraits, not actual patient reviews or treatment outcomes.
            Does the free assessment mean treatment is free?
            No. The assessment has no charge, while the terms list paid treatment packages.
            Is the lowest sermorelin figure the follow-up price?
            No. The terms describe $99 for the first month and $199 for follow-up.

            Sources

            • Current care model and illustrative formats
            • Treatment prices and refund restrictions
            • Geographic and data policy

            See what Peptivo prescribes today

            Peptivo sets its own prices, plans and the states it serves. Check them before you start.

            Written by Molly Ward from Peptivo’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.